As Pfizer PFE1.07%increase; green up pointing triangle prepares to close on its big merger, Allergan’s product portfolio looks as youthful as ever. Allergan reported fourth-quarter revenue from ...

Misty Keasler / The New York Times-Redux Because of Botox I don't have any wrinkles," says Allergan CEO David Pyott, whose 58-year-old forehead is as smooth as an aging Hollywood starlet's ...

But to dodge that deadline, Allergan is using another strategy; let's call it the "stay small and make weird products" approach. The company behind Botox, the "face-lift in a bottle," is itself ...

Revance also separately is developing medication that is biologically similar to Allergan’s Botox. Attorneys for Revance and a representative for the company did not immediately respond to ...

Allergan's cell line and manufacturing process is unique and proprietary, and Botox has other complexing proteins present as well as albumin. Competitors to Botox--like Dysport and Xeomin ...

Allergan pushes "Botox parties" that put people at risk of HIV and hepatitis because a "single-use" vial of the drug is used multiple times on different guests, according to a federal lawsuit ...

Allergan Inc., maker of the wrinkle smoother Botox, said second-quarter profit rose 6.9% as overseas sales of facial treatments and prescription eye-care products helped the Irvine company weather ...

Pharmaceutical company agrees to pay $600 million to settle Botox case. Sept. 2, 2010— -- Pharmaceutical manufacturer Allergan pled guilty for its off-label promotion of Botox and will pay $ ...

Allergan Inc. reported a 21% jump in third-quarter net income Monday on higher sales of the company’s anti-wrinkle drug, Botox. The Irvine-based company had net income of $92 million ...